chr19-8302551-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_016579.4(CD320):c.761G>A(p.Arg254Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000651 in 1,613,962 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_016579.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD320 | NM_016579.4 | c.761G>A | p.Arg254Gln | missense_variant | 5/5 | ENST00000301458.10 | NP_057663.1 | |
CD320 | NM_001165895.2 | c.635G>A | p.Arg212Gln | missense_variant | 4/4 | NP_001159367.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD320 | ENST00000301458.10 | c.761G>A | p.Arg254Gln | missense_variant | 5/5 | 1 | NM_016579.4 | ENSP00000301458 | P1 | |
CD320 | ENST00000596002.5 | c.*1049G>A | 3_prime_UTR_variant, NMD_transcript_variant | 5/5 | 1 | ENSP00000471773 | ||||
CD320 | ENST00000537716.6 | c.635G>A | p.Arg212Gln | missense_variant | 4/4 | 2 | ENSP00000437697 | |||
CD320 | ENST00000599573.1 | c.*361G>A | 3_prime_UTR_variant, NMD_transcript_variant | 5/5 | 2 | ENSP00000471551 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152096Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000319 AC: 8AN: 250942Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135688
GnomAD4 exome AF: 0.0000664 AC: 97AN: 1461748Hom.: 0 Cov.: 32 AF XY: 0.0000674 AC XY: 49AN XY: 727150
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152214Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74426
ClinVar
Submissions by phenotype
Methylmalonic acidemia due to transcobalamin receptor defect Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 13, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 426458). This variant has not been reported in the literature in individuals affected with CD320-related conditions. This variant is present in population databases (rs369347295, gnomAD 0.006%). This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 254 of the CD320 protein (p.Arg254Gln). - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Apr 15, 2017 | A variant of uncertain significance has been identified in the CD320 gene. The R254Q variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The R254Q variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is not conserved. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. In summary, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at